McCulloch Kevin 4
4 · Xeris Biopharma Holdings, Inc. · Filed Aug 4, 2025
Insider Transaction Report
Form 4
McCulloch Kevin
See Remarks
Transactions
- Tax Payment
Common Stock
2025-08-01$5.38/sh−14,651$78,822→ 1,701,159 total
Holdings
- 25,000(indirect: By Spouse)
Common Stock
- 2,000(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of restricted stock units vested as of August 1, 2025.
- [F2]These shares include 7,225 shares that were purchased on June 30, 2025 due to participation by the reporting individual in the issuer's 2018 Employee Stock Purchase Plan.
- [F3]The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.